<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0100757'>Pancreatoblastomas</z:hpo> are unusual malignant <z:hpo ids='HP_0002664'>neoplasms</z:hpo> of the pediatric pancreas that may also rarely affect adults </plain></SENT>
<SENT sid="1" pm="."><plain>The molecular pathogenesis of <z:hpo ids='HP_0100757'>pancreatoblastomas</z:hpo> is unknown </plain></SENT>
<SENT sid="2" pm="."><plain>They are clinicopathologically distinct from adult <z:mp ids='MP_0009151'>pancreatic ductal adenocarcinomas</z:mp>, but their occasional occurrence in patients with <z:e sem="disease" ids="C0004903" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Beckwith-Wiedemann syndrome</z:e> and the case presented here of a <z:hpo ids='HP_0100757'>pancreatoblastoma</z:hpo> in an adult patient with <z:e sem="disease" ids="C0032580" disease_type="Neoplastic Process" abbrv="">familial adenomatous polyposis</z:e> (FAP) suggests that they might bear a genetic similarity to other infantile <z:hpo ids='HP_0002898'>embryonal tumors</z:hpo> such as <z:hpo ids='HP_0002884'>hepatoblastomas</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>We analyzed a series of nine <z:hpo ids='HP_0100757'>pancreatoblastomas</z:hpo> for mutations common to other embryonal <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> including somatic alterations in the <z:mpath ids='MPATH_271'>adenomatous polyposis coli</z:mpath> (APC)/beta-catenin pathway and chromosome 11p, using immunohistochemistry for beta-catenin, 5q and 11p allelic loss assays, and direct DNA sequencing of exon 3 of the beta-catenin gene and the mutation cluster region of the APC gene </plain></SENT>
<SENT sid="4" pm="."><plain>In addition, we analyzed the <z:hpo ids='HP_0100757'>pancreatoblastomas</z:hpo> for alterations found in adult-type <z:mp ids='MP_0009151'>pancreatic ductal adenocarcinomas</z:mp> including mutations in the K-ras oncogene and the p53 and DPC4 <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor genes, using direct DNA sequencing of exon 1 of K-ras and immunohistochemistry for p53 and Dpc4 </plain></SENT>
<SENT sid="5" pm="."><plain>Allelic loss on chromosome 11p was the most common genetic alteration in <z:hpo ids='HP_0100757'>pancreatoblastomas</z:hpo>, present in 86% (six of seven informative cases) </plain></SENT>
<SENT sid="6" pm="."><plain>Molecular alterations in the APC/beta-catenin pathway were detected in 67% (six of nine), including five <z:hpo ids='HP_0002664'>neoplasms</z:hpo> with activating mutations of the beta-catenin oncogene and the one FAP-associated <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> with biallelic APC inactivation (germline truncating mutation combined with loss of the <z:mp ids='MP_0002169'>wild-type</z:mp> allele); seven <z:hpo ids='HP_0002664'>neoplasms</z:hpo> showed abnormal nuclear accumulation of beta-catenin protein </plain></SENT>
<SENT sid="7" pm="."><plain>In contrast, loss of Dpc4 protein expression was present in only two cases (one diffuse and one focal), and no alterations in the K-ras gene or p53 expression were detected </plain></SENT>
<SENT sid="8" pm="."><plain>Our findings indicate that <z:hpo ids='HP_0100757'>pancreatoblastomas</z:hpo> are genetically distinct from the more common <z:mp ids='MP_0009151'>pancreatic ductal adenocarcinomas</z:mp>, but bear a close molecular pathogenesis to <z:hpo ids='HP_0002884'>hepatoblastomas</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain>In addition, <z:hpo ids='HP_0100757'>pancreatoblastoma</z:hpo> may represent an extracolonic manifestation of FAP </plain></SENT>
</text></document>